Yahoo奇摩 網頁搜尋

搜尋結果

  1. 2022年7月20日 · The Biden administration is warning states to prepare for a "limited supply" of Novavax's COVID-19 vaccine to be made available, after federal health authorities cleared the shots for use on

  2. 2023年10月13日 · The FDA authorized Novavax to allow for a new adjuvanted 2023-24 vaccine for people ages 12 and older that targets the XBB1.5 strain in October. It is the only non-mRNA updated COVID vaccine ...

  3. 2021年1月28日 · Novavax Inc. said Thursday that its COVID-19 vaccine appears 89% effective based on early findings from a British study and that it also seems to work — though not as well ...

  4. 2022年7月19日 · After reviewing the two-dose Novavax vaccine’s safety and efficacy data, the FDA’s panel of experts approved it last month for emergency use in adults ages 18 and older, recommending that ...

  5. 2022年9月1日 · LONDON (Reuters) - The European Medicines Agency (EMA) on Thursday backed the use of Novavax's COVID-19 shot as a booster for adults, ahead of an anticipated rise in infections this winter. The ...

  6. 2022年7月1日 · Novavax expects additional preclinical data on shots tailored against the fast-spreading Omicron subvariants in late summer or fall. The U.S. FDA on Thursday recommended COVID-19 vaccine ...

  7. 2023年10月4日 · The Novavax shot now includes a spike protein — a pointy structure found on the virus's surface — from a version of the virus that is currently circulating, called XBB.1.5.